Is This Stock a Buy on the Dip?
After becoming the first healthcare stock to hit a $1 trillion market valuation in late 2025, Eli Lilly (LLY 1.29%) hasn’t performed well since, with its shares down about 19% from their 52-week high of $1133.95. Some are worried about the company’s runaway valuation, while others fear that, even as the drugmaker leads the market…